| abstract |
The present invention relates to compounds of formula (I) that are inhibitors of the NF-? B-inducing kinase (NIK - also known as MAP3K14) that are useful for treating diseases such as cancer, inflammatory disorders, metabolic disorders and autoimmune disorders; the invention also relates to pharmaceutical compositions comprising said compounds, to processes for preparing said compounds and compositions and to the use of such compounds or pharmaceutical compositions in the prevention or treatment of diseases such as cancer, inflammatory disorders, metabolic disorders They include obesity and diabetes, and autoimmune disorders. |